BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3261998)

  • 1. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide].
    Kondrat'eva TK; Mikheeva NV; Fontalin LN
    Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of polyclonal tolerance induced by lipopolysaccharide and cyclophosphamide].
    Kondrat'eva TK; Fontalin LN; Mikheeva NV; Golan' V
    Biull Eksp Biol Med; 1987 Oct; 104(10):483-5. PubMed ID: 3118987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic modifications induced by cyclophosphamide in C3H/He, nude, and "B" mice.
    Kolb JP; Poupon MF; Lespinats GM; Sabolovic D; Loisillier F
    J Immunol; 1977 May; 118(5):1595-9. PubMed ID: 300749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
    Shand FL
    Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW; Mokyr MB
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on induction and control of cell-mediated autoimmunity. II. Prevention of induction and activity of autoreactive T cells by suppressor cells and by a suppressive serum factor.
    L'age-Stehr J; Diamantstein T
    Eur J Immunol; 1978 Sep; 8(9):624-8. PubMed ID: 309399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells.
    Schwartz A; Askenase PW; Gershon RK
    J Immunol; 1978 Oct; 121(4):1573-7. PubMed ID: 308970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced immunological unresponsiveness: selective inhibition of T-cell 'helper function' by cyclophosphamide in mice pretreated with phytohaemagglutinin.
    Schwarze G
    Clin Exp Immunol; 1977 Jan; 27(1):178-82. PubMed ID: 321157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A technique for inducing B-cell ablation in chickens by in ovo injection of cyclophosphamide.
    Reynolds DL; Maraqa AD
    Avian Dis; 1999; 43(3):367-75. PubMed ID: 10494404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Participation of lymphoid organ T- and B-lymphocytes in transplantation immunity in immune deficiency modeled with anti-thymus serum and cyclophosphamide].
    Antonenko VT; Chornen'ka VD
    Fiziol Zh; 1977; 23(6):733-40. PubMed ID: 338369
    [No Abstract]   [Full Text] [Related]  

  • 13. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions.
    Schwartz A; Orbach-Arbouys S; Gershon RK
    J Immunol; 1976 Sep; 117(3):871-5. PubMed ID: 8571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
    Bruley-Rosset M; Payelle B; Rappaport H
    J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between T- and B-lymphocyte cooperation and their syngeneity].
    Fontalin LN; Novikova TK; PevnitskiÄ­ LA; Kondrat'eva IA
    Biull Eksp Biol Med; 1976 Mar; 81(3):325-7. PubMed ID: 1085176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on induction and control of cell-mediated autoimmunity. I. Induction of "autoreactive" T lymphocytes in mice by cyclophosphamide.
    L'age-Stehr J; Diamantstein T
    Eur J Immunol; 1978 Sep; 8(9):620-4. PubMed ID: 309398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular control of delayed hypersensitivity to Staphylococcus aureus in mice.
    Easmon CS; Glynn AA
    Immunology; 1979 Sep; 38(1):103-8. PubMed ID: 159861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal B cell anergy induced by bacterial lipopolysaccharide and cyclophosphamide.
    Fontalin LN; Kondratieva TK; Kondratieva IA; Smirnova IN; Mikheeva NV
    Folia Biol (Praha); 1988; 34(2):72-83. PubMed ID: 3294050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
    Sihvola M; Hurme M
    J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.